可孚医疗
(301087)
| 流通市值：100.95亿 | | | 总市值：122.76亿 |
| 流通股本：1.94亿 | | | 总股本：2.36亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 3,190,990,989.37 | 2,071,847,991.36 | 1,012,368,240.57 | 3,387,499,253.24 |
| 营业收入 | 3,190,990,989.37 | 2,071,847,991.36 | 1,012,368,240.57 | 3,387,499,253.24 |
| 二、营业总成本 | 2,852,162,092.66 | 1,846,039,389.15 | 885,037,584.77 | 3,038,805,623.01 |
| 营业成本 | 1,396,494,874.36 | 913,936,420.44 | 454,005,528.45 | 1,586,607,952.8 |
| 税金及附加 | 29,954,472.6 | 20,210,841.72 | 10,478,524.57 | 36,650,011.16 |
| 销售费用 | 1,200,707,488.2 | 762,754,256.12 | 352,910,826.12 | 1,158,175,337.61 |
| 管理费用 | 135,523,011.74 | 86,058,954.87 | 43,977,336.58 | 173,075,388.29 |
| 研发费用 | 79,921,785.54 | 52,011,248.54 | 22,089,607.15 | 87,284,427.95 |
| 财务费用 | 9,560,460.22 | 11,067,667.46 | 1,575,761.9 | -2,987,494.8 |
| 其中:利息费用 | 13,795,537.93 | 9,606,080.98 | 2,895,462.23 | 16,066,144.73 |
| 其中:利息收入 | 29,339,321.16 | 14,075,832.7 | 6,175,523.59 | 26,428,809.15 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 22,555,871.71 | 19,846,399.43 | 5,131,738.53 | 49,842,350.95 |
| 加:投资收益 | -8,693,136.47 | -5,184,896.42 | -2,733,668.78 | 15,844,585.29 |
| 资产处置收益 | 603,787.11 | 599,369.13 | 72,734 | -1,369,618.79 |
| 资产减值损失(新) | -19,560,021.21 | -16,878,832.55 | -16,363,970.5 | -31,813,342.75 |
| 信用减值损失(新) | -1,228,124.74 | -1,006,682.4 | 92,367.59 | -2,010,463.9 |
| 其他收益 | 33,445,208.6 | 21,230,104.79 | 15,136,311.84 | 49,857,199.62 |
| 四、营业利润 | 365,952,481.71 | 244,414,064.19 | 128,666,168.48 | 429,044,340.65 |
| 加:营业外收入 | 2,384,612.66 | 1,535,870.13 | 1,100,599.72 | 4,181,077.56 |
| 减:营业外支出 | 2,951,305.76 | 1,879,644.13 | 734,570.75 | 7,382,611.1 |
| 五、利润总额 | 365,385,788.61 | 244,070,290.19 | 129,032,197.45 | 425,842,807.11 |
| 减:所得税费用 | 58,798,117.4 | 40,871,208.06 | 21,620,438.46 | 55,526,592.12 |
| 六、净利润 | 306,587,671.21 | 203,199,082.13 | 107,411,758.99 | 370,316,214.99 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 306,587,671.21 | 203,199,082.13 | 107,411,758.99 | 370,316,214.99 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 305,244,714.07 | 202,263,774.19 | 107,041,703.68 | 371,608,606.66 |
| 少数股东损益 | 1,342,957.14 | 935,307.94 | 370,055.31 | -1,292,391.67 |
| 扣除非经常损益后的净利润 | 269,524,480.01 | 172,597,647.33 | 93,790,509.89 | 297,965,673.28 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.4 | 0.95 | 0.52 | 1.83 |
| (二)稀释每股收益 | 1.38 | 0.94 | 0.51 | 1.81 |
| 八、其他综合收益 | -24,672,738.89 | -6,576,014.49 | -2,847,497.23 | -1,767,715.86 |
| 归属于母公司股东的其他综合收益 | -21,010,290.33 | -5,760,588.69 | -2,496,685.57 | -1,548,497.7 |
| 九、综合收益总额 | 281,914,932.32 | 196,623,067.64 | 104,564,261.76 | 368,548,499.13 |
| 归属于母公司股东的综合收益总额 | 284,234,423.74 | 196,503,185.5 | 104,545,018.11 | 370,060,108.96 |
| 归属于少数股东的综合收益总额 | -2,319,491.42 | 119,882.14 | 19,243.65 | -1,511,609.83 |
| 公告日期 | 2026-10-30 | 2026-08-29 | 2026-04-30 | 2026-03-10 |
| 审计意见(境内) | | | | 标准无保留意见 |